XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY (unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Retained Earnings
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Jan. 01, 2022   7,362,703    
Beginning balance at Jan. 01, 2022 $ 205,834 $ 0 $ 215,784 $ (9,950)
Increase (Decrease) in Shareholders' Equity        
Net income 11,426   11,426  
Foreign currency translation adjustment (1,172)     (1,172)
Exercise of stock options 341 $ 341    
Exercise of stock options (in shares)   14,552    
Share-based compensation expense 1,037 $ 1,037    
Restricted shares vesting (in shares)   29,558    
Redemption of vested employee restricted shares for tax withholding (in shares)   (10,163)    
Redemption of vested employee restricted shares for tax withholding (897) $ (897)    
Shares repurchased (in shares)   (56,665)    
Shares repurchased (4,956) $ (481) (4,475)  
Accrued dividends on unvested shares (11)   (11)  
Cash dividends paid (per share) (2,377)   (2,377)  
Ending balance (in shares) at Apr. 02, 2022   7,339,985    
Ending balance at Apr. 02, 2022 $ 209,225 $ 0 220,347 (11,122)
Increase (Decrease) in Shareholders' Equity        
Common share quarterly cash dividend declared (in dollars per share) $ 0.31      
Beginning balance (in shares) at Jan. 01, 2022   7,362,703    
Beginning balance at Jan. 01, 2022 $ 205,834 $ 0 215,784 (9,950)
Increase (Decrease) in Shareholders' Equity        
Net income 23,069      
Foreign currency translation adjustment (5,032)      
Ending balance (in shares) at Jul. 02, 2022   7,131,349    
Ending balance at Jul. 02, 2022 197,986 $ 0 212,968 (14,982)
Beginning balance (in shares) at Apr. 02, 2022   7,339,985    
Beginning balance at Apr. 02, 2022 209,225 $ 0 220,347 (11,122)
Increase (Decrease) in Shareholders' Equity        
Net income 11,643   11,643  
Foreign currency translation adjustment (3,860)     (3,860)
Share-based compensation expense 1,041 $ 1,041    
Restricted shares vesting (in shares)   3,630    
Redemption of vested employee restricted shares for tax withholding (in shares)   (921)    
Redemption of vested employee restricted shares for tax withholding (78) $ (78)    
Shares repurchased (in shares)   (211,345)    
Shares repurchased (17,674) $ (963) (16,711)  
Accrued dividends on unvested shares (52)   (52)  
Cash dividends paid (per share) (2,259)   (2,259)  
Ending balance (in shares) at Jul. 02, 2022   7,131,349    
Ending balance at Jul. 02, 2022 $ 197,986 $ 0 212,968 (14,982)
Increase (Decrease) in Shareholders' Equity        
Common share quarterly cash dividend declared (in dollars per share) $ 0.31      
Beginning balance (in shares) at Dec. 31, 2022 7,149,884 7,149,884    
Beginning balance at Dec. 31, 2022 $ 211,154 $ 1,743 224,392 (14,981)
Increase (Decrease) in Shareholders' Equity        
Net income 8,918   8,918  
Foreign currency translation adjustment 1,052     1,052
Exercise of stock options 0 $ 0    
Exercise of stock options (in shares)   0    
Share-based compensation expense 940 $ 940    
Restricted shares vesting (in shares)   45,544    
Redemption of vested employee restricted shares for tax withholding (in shares)   (16,614)    
Redemption of vested employee restricted shares for tax withholding (1,873) $ (1,873)    
Shares repurchased (in shares)   (180,881)    
Shares repurchased (20,577) $ (810) (19,767)  
Accrued excise tax on shares repurchased (173)   (173)  
Accrued dividends on unvested shares 45   45  
Cash dividends paid (per share) (2,702)   (2,702)  
Ending balance (in shares) at Apr. 01, 2023   6,997,933    
Ending balance at Apr. 01, 2023 $ 196,784 $ 0 210,713 (13,929)
Increase (Decrease) in Shareholders' Equity        
Common share quarterly cash dividend declared (in dollars per share) $ 0.36      
Beginning balance (in shares) at Dec. 31, 2022 7,149,884 7,149,884    
Beginning balance at Dec. 31, 2022 $ 211,154 $ 1,743 224,392 (14,981)
Increase (Decrease) in Shareholders' Equity        
Net income 18,426      
Foreign currency translation adjustment $ 2,126      
Ending balance (in shares) at Jul. 01, 2023 6,969,236 6,969,236    
Ending balance at Jul. 01, 2023 $ 202,786 $ 468 215,173 (12,855)
Beginning balance (in shares) at Apr. 01, 2023   6,997,933    
Beginning balance at Apr. 01, 2023 196,784 $ 0 210,713 (13,929)
Increase (Decrease) in Shareholders' Equity        
Net income 9,508   9,508  
Foreign currency translation adjustment 1,074     1,074
Exercise of stock options 0 $ 0    
Exercise of stock options (in shares)   0    
Share-based compensation expense 1,158 $ 1,158    
Restricted shares vesting (in shares)   3,630    
Redemption of vested employee restricted shares for tax withholding (in shares)   (1,237)    
Redemption of vested employee restricted shares for tax withholding (136) $ (136)    
Shares repurchased (in shares)   (31,090)    
Shares repurchased (3,000) $ (554) (2,446)  
Accrued excise tax on shares repurchased (27)   (27)  
Accrued dividends on unvested shares (47)   (47)  
Cash dividends paid (per share) $ (2,528)   (2,528)  
Ending balance (in shares) at Jul. 01, 2023 6,969,236 6,969,236    
Ending balance at Jul. 01, 2023 $ 202,786 $ 468 $ 215,173 $ (12,855)
Increase (Decrease) in Shareholders' Equity        
Common share quarterly cash dividend declared (in dollars per share) $ 0.36